Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation CCVVC 2016

Global Perspective on Cardiovascular Health

Presenter: Salim Yusuf

June 16, 2016

Presentation CCVVC 2016

Bioresorbable Scaffold Implantation Optimization

Presenter: Alexandre Abizaid

June 16, 2016

Presentation CCVVC 2016

Anti-Thrombotic Therapy for PCI

Presenter: Deepak L. Bhatt

June 16, 2016

Presentation CCVVC 2016

Biodegradable vs Durable Polymer DES Outcomes

Presenter: Ajay J. Kirtane

June 16, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Bifurcation Lesion Intervention: Preferred Two Stent Strategy

Presenter: Vinay K. Bahl

June 16, 2016

Presentation CCVVC 2016

Subclinical Leaflet Thrombosis Post-TAVR

Presenter: Gian Paolo Ussia

June 16, 2016

Presentation CCVVC 2016

STEMI Process Improvement: Global Perspective

Presenter: Sameer Mehta

June 16, 2016

Presentation CCVVC 2016

Top 10 Advances of Interventional Cardiology 2015

Presenter: Samin K Sharma

June 16, 2016

Presentation CCVVC 2016

Telemedicine in Interventional Cardiology

Presenter: Roberto Botelho

June 16, 2016

Presentation CCVVC 2016

STEMI Process Improvement: Global Perspective

Presenter: Sameer Mehta

June 16, 2016

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation CCVVC 2016

CTO Intervention: Current Indications and Results

Presenter: Paul S. Teirstein

June 16, 2016

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation CCVVC 2016

Where does drug-coated technology fit into the treatment of CLI?

Presenter: Dierk Scheinert

June 15, 2016

Presentation CCVVC 2016

Update on the Latest European and US Clinical Data on Drug Coated Balloons

Presenter: Fabrizio Fanelli

June 15, 2016

Presentation CCVVC 2016

The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions

Presenter: Chris Metzger

June 15, 2016

Presentation CCVVC 2016

The role of Atherectomy and Drug Eluting Balloons

Presenter: Mark Wholey

June 15, 2016

Presentation CCVVC 2016

Pathology of Drug Eluting Technologies: Are There Differences?

Presenter: Renu Virmani

June 15, 2016

Presentation CCVVC 2016

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Presenter: Marc P. Bonaca

June 15, 2016

Advertisement

Global Perspective on Cardiovascular Health

Bioresorbable Scaffold Implantation Optimization

Anti-Thrombotic Therapy for PCI

Biodegradable vs Durable Polymer DES Outcomes

Timing of DAPT Interruption and DES Thrombosis

Bifurcation Lesion Intervention: Preferred Two Stent Strategy

Subclinical Leaflet Thrombosis Post-TAVR

STEMI Process Improvement: Global Perspective

Top 10 Advances of Interventional Cardiology 2015

Telemedicine in Interventional Cardiology

STEMI Process Improvement: Global Perspective

Optimal Duration of DAPT: Update on DAPT Guidelines

CTO Intervention: Current Indications and Results

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Where does drug-coated technology fit into the treatment of CLI?

Update on the Latest European and US Clinical Data on Drug Coated Balloons

The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions

The role of Atherectomy and Drug Eluting Balloons

Pathology of Drug Eluting Technologies: Are There Differences?

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content